
Story Highlight
A new Spot CEX Report 2026 from CoinGecko showcases a tough reality for the market: only around 32% of newly listed tokens on major centralized exchanges (CEXs) show positive price action within their first 30 days.
That means nearly 7 out of 10 tokens fail to hold their value almost immediately after launch.
Even for the minority that start strong, the upside doesn’t last. By the 30–59-day window, only about 25% of tokens remain in profit.
From there, the decline is steady and predictable. Over longer time frames, performance drops almost linearly across exchanges. By the end of 12 months, fewer than 10% of tokens are still trading above their initial listing price.
This shows that most of the listing rallies are driven by short-term hype rather than sustained demand.
Performance varies widely depending on where a token is listed.
However, even the best performers don’t escape the long-term trend. Upbit’s listings, despite strong starts, all fall below their initial price within roughly 300 days, showing how quickly early gains can reverse.
Coinbase behaves slightly different. Tokens listed there tend to see a “second wind” after about six months, suggesting delayed accumulation or stronger investor confidence over time.
Meanwhile, liquidity plays a major role here. Stablecoins like Tether and USD Coin dominate trading, accounting for roughly 66% of all pairs. This concentration limits capital flowing into new tokens.
At the same time, high-volume listings and strong initial attention don’t guarantee performance. Many investors chase early gains, only to face sharp corrections once the hype fades.
Security firms Blockaid and PeckShield say the same attacker hit two separate AI-focused crypto projects…
Someone with deep pockets just moved $2 billion into XRP in under a week, and…
BNB price has climbed roughly 44% from the July 1 low of $538 to $769…
Bitcoin price has bounced sharply from the September 15 low, but on-chain data suggests long-term…
ZEC price has moved far beyond a routine altcoin rally. The token surged close to…
Injective price surged over 17% as the broader crypto market moves higher, with fresh institutional…